Provexis shares dropped from about €0.16 in the wake of the announcement that the company was in talks with both individual and institutional investors.
Provexis recently won a positive health claim opinion from the European Food Safety Authority (EFSA) for a claim linking consumption of its proprietary Fruitflow tomato extract and blood circulation benefits.
It is the only company to earn a positive article 13.5 opinion so far.





